| 000 | 01641 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516230944.0 | ||
| 264 | 0 | _c20150612 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1439-3646 | ||
| 024 | 7 |
_a10.1055/s-0034-1376987 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiebl, A | |
| 245 | 0 | 0 |
_aHealth economics analysis of insulin aspart vs. regular human insulin in type 2 diabetes patients, based on observational real life evidence from general practices in Germany. _h[electronic resource] |
| 260 |
_bExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _cOct 2014 |
||
| 300 |
_a517-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 |
_aDiabetes Complications _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGeneral Practice |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin Aspart _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Econometric |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSeitz, L | |
| 700 | 1 | _aPalmer, A J | |
| 773 | 0 |
_tExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association _gvol. 122 _gno. 9 _gp. 517-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0034-1376987 _zAvailable from publisher's website |
| 999 |
_c24121797 _d24121797 |
||